Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy
Claritev (NYSE: CTEV) has announced two key appointments to strengthen its leadership team as part of its business transformation strategy.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Jigar S. Patel, MD, Named Chief Medical Officer
Fernando Schwartz, Ph.D., Named Chief Artificial Intelligence Officer
Jigar S. Patel, MD, has been appointed Chief Medical Officer effective April 14, 2025. As a new member of the Executive Leadership Team, Patel will provide medical guidance on the strategic development and product innovation of Claritev’s healthcare technology and network optimization solutions. Patel brings deep expertise in healthcare delivery, medical network dynamics and industry relationships. This experience will be integral as he works to align Claritev’s products with the evolving needs of the industry, including health plans, payors and other medical organizations. Prior to joining Claritev, Patel spent more than 18 years at Cerner/Oracle where he worked with large national healthcare companies on all aspects of their Healthcare Information Technology needs and strategy.
Fernando Schwartz, Ph.D., has been appointed Chief Artificial Intelligence Officer effective February 17, 2025. Schwartz leads the AI and Data Science Department on Chief Digital Officer Michael Kim’s team. Bringing 15 years of leadership in data science and machine learning, Schwartz will lead the Company’s AI and analytics strategy as well as new product development and capabilities that will benefit existing and new clients or partners. Prior to joining Claritev, Schwartz most recently served as the Vice President of AI at ADP. Before that, he led the global data science strategy for Merck’s Human Health Division as the Associate Vice President and Global Head of Data Science.
“Today’s announcement marks a pivotal moment in Claritev’s strategic transformation journey,” said Travis Dalton, Chairman, CEO and President of Claritev. “With their past industry experience and expertise, Jigar’s and Fernando’s roles will bring us a step closer to providing cutting-edge innovation and technology that promote more affordable, transparent and higher quality healthcare services.
About Claritev
Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the
Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250417495531/en/
Media Relations
Pamela Walker
VP, Marketing & Communication
Claritev
781-895-3118
press@claritev.com
Investor Relations
Jason Wong
SVP, Treasury & Investor Relations
Claritev
866-909-7427
investor@claritev.com
Shawna Gasik
AVP, Investor Relations
Claritev
866-909-7427
investor@claritev.com
Source: Claritev Corporation